Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells
Yi Yu(Obstetrics and Gynecology Hospital of Fudan University), Congjian Xu(Shanghai Medical College of Fudan University)
Cited by 22
Related Papers
The expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: a novel target for combination therapy
|British Journal of Cancer|2014|27
Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells
|Journal of Hematology & Oncology|2014|27
Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A2 in ovarian cancer cells
|Journal of Ovarian Research|2014|23
An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer
|Cancer Chemotherapy and Pharmacology|2022|16
Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells
|Journal of Experimental & Clinical Cancer Research|2014|3